CPHI North America (7 – 9 May, 2024) will open at Pennsylvania Convention Centre in Philadelphia as the event sees as a doubling of attendees across purchasing and procurement, R&D, manufacturing, QC and QA.
The rapid increase is attributed to both a concerted effort by Informa to attract larger buying audiences, but is also seen as a response by the US industry to macro trends, with alternative supply chain options actively being sought out by both pharma and biotech companies.
“We have spent a good deal of time researching and investing resources to target these audiences in the last 12-months – in response to exhibitor feedback – but it also shows the strong desire we see among US based companies to seek out alternative supply options and new partners. Our role is to actively help facilitate these discussions and build an ecosystem of much large networking opportunities at the event. Companies across the industry have taken note of developments that might affect supply – particularly among the largest CDMOs – and we are here to help them navigate their options and find new suppliers,” commented Sarah Griffin, Manager, Pharma Brand US at Informa Markets.
The 2024 event will host more than 350 exhibitors and will include three new engagement zones – covering sustainability, innovation and growth & development [designed to help promote job opportunities and encourage career development conversations] – alongside the first ever Start-Up Market; a dedicated space where smaller innovators and enterprises from the industry can exhibit their exciting new products and solutions.
"CPHI North America is the only show bringing the entire US Pharma supply chain together under one roof - in person, and thanks to our online event platforms our attendees and exhibitors are already making new connections ahead of the event and actively taking forward discussion to forge crucial supply chain partnerships." Said Adam Andersen, Informa’s Executive Vice President, Pharma.
This year’s conference features 4 tracks – spanning ‘Sustainable Futures’, ‘Revolutionising Drug Manufacturing’, ‘Supply Chain Economy’, and ‘Exploring Excipients’ – as well as a breakfast session on manufacturing excellence and the CDMO roundtable.
The latter is particularly timely, with US based Manufacturers in high demand in 2024. In total CPHI North American features 50+ experts spanning dozens of sessions that encompass the entire pharmaceutical development and supply chain, with seminars covering themes as varied as ‘marketing’, ‘diversity’ and ‘well-being’.
Additionally, in a further sign of pharma’s increased social responsibility, the new sustainability zone will also host a ‘commitments communication area’: where companies go to publicly pledge their goals and targets for environmental, sustainability or governance over the next few years.
